Can a multivariable approach including magnetic resonance imaging (MRI) safely prevent unnecessary protocol-advised repeat biopsy during active surveillance (AS)? The international multicentre prospective PRIAS study concluded that age, MRI outcome, PSA density, and percentage positive cores are significant predictors of reclassification at an MRI-informed biopsy.

Read more here and also the expert commentary by the chief editor of the EAU Edu Platform on Prostate Cancer, Dr. R. Van den Bergh.

The recent American Uurological Association annual meeting, which took place from 13 to 16 May 2022 in New Orleans, delivered crucial updates on prostate cancer treatment and management.

You can read Prof. Tsaur’s overview of the PCa highlights and vital findings presented at the annual meeting here.

Our Europa Uomo General Assembly 2022 is gradually getting closer. GA participants have received the last information package with the full programme and GA documents.
Thanks to our Dutch member group PKS, we will have an interesting Masterclass on Friday and a great social event on Saturday afternoon to have some time together after two years of virtual meetings.

We look forward to meet our EUomo delegates in Leusden, the Netherlands next June 9-12, 2022.

On June 1 at 2AM CET Steven A Kaplan, Professor of Urology at Mount Sinai in the US and BPH expert will discuss “Living with BPH”.

Many men on AS find urinary issues at times more irritating than dealing with prostate cancer.  Urgency,  frequency, nocturnal urination are common problems.  This programme will offer some alternatives.

Everyone is welcome to attend. No registration is required. http://ancan.org/barniskis